UBS Group »

Edgewise Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Edgewise Therapeutics

Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 202501M2M020k40k60k80k
Value ($)Share countHistorical EWTX position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.5M 92k 26.70
2024-09-30 $2.0M 75k 26.69
2024-06-30 $1.1M 61k 18.01
2024-03-31 $1.4M 74k 18.24
2022-12-31 $14k 1.6k 8.94
2022-03-31 $214k 22k 9.71
2021-06-30 $19k 868 21.89